EUVIMEDEUVIMED entdecken
Crossref

DESIGN, SYNTHESIS AND BIOLOGICAL ESTIMATION OF INNOVATIVE PYRAZOLES AS ANTICANCER AGENTS TARGETING CDK2

Diaa Ibrahim, Ibrahim Radini, Rizk KHIDRE

Acta Poloniae Pharmaceutica - Drug Research · 2019

DOI: 10.32383/appdr/102651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Poloniae Pharmaceutica - Drug Research, 2019. Verfasst von Diaa Ibrahim und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ibrahim, D., Radini, I., & KHIDRE, R. (2019). DESIGN, SYNTHESIS AND BIOLOGICAL ESTIMATION OF INNOVATIVE PYRAZOLES AS ANTICANCER AGENTS TARGETING CDK2. Acta Poloniae Pharmaceutica - Drug Research. https://doi.org/10.32383/appdr/102651

Vancouver

Ibrahim D, Radini I, KHIDRE R. DESIGN, SYNTHESIS AND BIOLOGICAL ESTIMATION OF INNOVATIVE PYRAZOLES AS ANTICANCER AGENTS TARGETING CDK2. Acta Poloniae Pharmaceutica - Drug Research. 2019. doi:10.32383/appdr/102651

BibTeX
@article{Ibrahim2019,
  author = {Ibrahim, Diaa and Radini, Ibrahim and KHIDRE, Rizk},
  title = {DESIGN, SYNTHESIS AND BIOLOGICAL ESTIMATION OF INNOVATIVE PYRAZOLES AS ANTICANCER AGENTS TARGETING CDK2},
  journal = {Acta Poloniae Pharmaceutica - Drug Research},
  year = {2019},
  doi = {10.32383/appdr/102651}
}
Kostenlos starten →